Rolf Bergman
Inventor
Stats
- 7 US patents issued
- 10 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 7 US Patents Issued
- 10 US Applications Filed
- 119 Total Citation Count
- Feb 14, 2012 Most Recent Filing
- May 21, 1998 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
AMO Regional Holdings | 1
1 1 | 2006
2009 2011 |
ALBIREO AB | 2
| 2006
|
ABBOTT MEDICAL OPTICS INC. | 1
2 1 | 2006
2009 2011 |
ASTRAZENECA AB | 2
1 | 2001
2007 |
GENERAL ELECTRIC COMPANY | 1
| 1998
|
Cree, Inc. | 1
| 2011
|
AMO GRONINGEN B.V. | 2
2 2 | 2003
2005 2009 |
Inventor Addresses
Address | Duration |
---|---|
Cleveland Heights, OH | Jun 26, 01 - Jun 26, 01 |
Molndal, SE | Aug 15, 02 - Oct 16, 12 |
Uppsala, SE | Feb 26, 04 - Mar 05, 13 |
Technology Profile
Technology | Matters | |
---|---|---|
A61B: | DIAGNOSIS; SURGERY; IDENTIFICATION | 2 |
A61F: | FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS | 4 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 5 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
8388601 | 2013 | Viscoelastic solution or gel formulation, and methods of treating a body site with the same | 0 |
8288370 | 2012 | Substituted azetidine compounds of formula (I) useful in the treatment of functional gastrointestinal disorders, IBS, and functional dyspepsia | 0 |
2012/0207,701 | 2012 | BI-MODAL HYALURONATE | 0 |
8182088 | 2012 | Systems and methods for determining intraocular lens power | 2 |
2011/0128,502 | 2011 | SYSTEMS AND METHODS FOR DETERMINING INTRAOCULAR LENS POWER | 4 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.